Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeVuzix CorporationVuzix® Corporation Announces Pixee Medical Completes its First Total Knee Replacement Surgery...

Vuzix® Corporation Announces Pixee Medical Completes its First Total Knee Replacement Surgery Guided Solely by the Vuzix M400 Smart Glasses

September 2, 2020

Vuzix M400 Smart Glasses: Vuzix® Corporation a supplier of Smart Glasses and Augmented Reality (AR) technology and products, announce that Pixee Medical, a France-based medical company, in collaboration with Dr. Jérôme Villeminot and his team from Clinique St Odile in Haguenau (France), has successfully validated a new milestone by using Knee+, the first total knee replacement AR navigation system, solely guided by the Vuzix M400 AR Smart Glasses.

Vuzix M400 Smart Glasses running the Knee+ solution provided real-time navigation throughout the surgery, displaying essential augmented reality information in the surgeon’s field of view.

The most recent surgery also marked the first ambulatory surgery using Pixee’s MIS solution.  During the last 2 months, Pixee successfully achieved the first round of the Knee+ clinical validation program. This major milestone starts the second round of validation, opening the way to the first limited commercialization of their innovative solution in November 2020.  Pixee has a growing list of surgeons and orthopedic manufacturers worldwide interested in trying this innovation using the Vuzix M400 Smart Glasses. The combination is compact, easy to use, wireless, and does not require disposables.

“The team at Pixee Medical created an innovative path to bring the Vuzix M400 Smart Glasses into the operating room to perform knee replacement surgeries and continues to make progress in the operating theater for a variety of uses.  We look forward to supporting them in their worldwide distribution of this innovative AR solution,” said Paul Travers, President, and Chief Executive Officer at Vuzix.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy